TLR4 and HMGB1: partners in crime?

Kidney Int. 2011 Sep;80(5):450-2. doi: 10.1038/ki.2011.170.

Abstract

Chen et al. confirmed the role of Toll-like receptor 4 (TLR4) in ischemic kidney injury using mice harboring spontaneous disabling mutations of the receptor and generated chimeras between TLR4-/- and TLR4+/+ mice. The major findings demonstrate the necessity of TLR4 in leukocytes, as well as in epithelial and endothelial cells, for the full-blown ischemic response and strongly suggest that the release of high-mobility group box 1 protein (HMGB1) from injured epithelia and/or endothelia activates leukocytes to generate proinflammatory cytokines, further exacerbating the injury to ischemic kidneys. These important findings provide an excellent platform for discussing the complexity of danger/alarm signaling in the kidney.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Acute Kidney Injury / immunology*
  • Animals
  • Interleukin-6 / biosynthesis*
  • Leukocytes / metabolism*
  • Male
  • Toll-Like Receptor 4 / physiology*

Substances

  • Interleukin-6
  • Tlr4 protein, mouse
  • Toll-Like Receptor 4